encainide
{{short description|Chemical compound}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 461093505
| IUPAC_name = 4-Methoxy-N-[2-(1-methyl-2-piperidin-1-ylethyl)phenyl]benzamide
| image = Encainide.svg
| tradename = Enkaid
| Drugs.com = {{drugs.com|CONS|encainide}}
| MedlinePlus = a605040
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_UK =
| legal_US =
| legal_status = Withdrawn
| routes_of_administration =
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 66778-36-7
| ATC_prefix = C01
| ATC_suffix = BC08
| ATC_supplemental =
| PubChem = 48041
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01228
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 315838
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 43697
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = SY3J0147NB
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07894
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 4788
| C=22 | H=28 | N=2 | O=2
| smiles = COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H28N2O2/c1-24-16-6-5-8-19(24)13-10-17-7-3-4-9-21(17)23-22(25)18-11-14-20(26-2)15-12-18/h3-4,7,9,11-12,14-15,19H,5-6,8,10,13,16H2,1-2H3,(H,23,25)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = PJWPNDMDCLXCOM-UHFFFAOYSA-N
}}
Encainide (trade name Enkaid) is a class Ic antiarrhythmic agent. It is no longer used because of its frequent proarrhythmic side effects.{{cite journal | vauthors = Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL | display-authors = 6 | title = Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial | journal = The New England Journal of Medicine | volume = 324 | issue = 12 | pages = 781–8 | date = March 1991 | pmid = 1900101 | doi = 10.1056/NEJM199103213241201 | doi-access = free }}
Synthesis
See also
References
{{reflist}}
{{Sodium channel blockers}}
{{Antiarrhythmic agents}}
Category:Antiarrhythmic agents
Category:4-Methoxyphenyl compounds
Category:Sodium channel blockers
{{cardiovascular-drug-stub}}